Last reviewed · How we verify
Atorvastatin-pantoprazole — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Atorvastatin-pantoprazole (Atorvastatin-pantoprazole) — Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Atorvastatin-pantoprazole TARGET | Atorvastatin-pantoprazole | Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Atorvastatin-pantoprazole CI watch — RSS
- Atorvastatin-pantoprazole CI watch — Atom
- Atorvastatin-pantoprazole CI watch — JSON
- Atorvastatin-pantoprazole alone — RSS
Cite this brief
Drug Landscape (2026). Atorvastatin-pantoprazole — Competitive Intelligence Brief. https://druglandscape.com/ci/atorvastatin-pantoprazole. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab